TrialPloS one2015

Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study).

Yoshie Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.